These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18959484)

  • 21. Who owns federally funded research? The Supreme court and the Bayh-Dole act.
    Kesselheim AS; Rajkumar R
    N Engl J Med; 2011 Sep; 365(13):1167-9. PubMed ID: 21879888
    [No Abstract]   [Full Text] [Related]  

  • 22. Use the Bayh-Dole Act to lower drug prices for government healthcare programs.
    Engelberg AB; Kesselheim AS
    Nat Med; 2016 Jun; 22(6):576. PubMed ID: 27270771
    [No Abstract]   [Full Text] [Related]  

  • 23. Patent and license pearls and pitfalls for taking an idea to the marketplace.
    Mukharji I
    J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The demise of Bayh-Dole protections against the Pharmaceutical Industry's abuses of government-funded inventions.
    Schofield AR
    J Law Med Ethics; 2004; 32(4):777-83. PubMed ID: 15807367
    [No Abstract]   [Full Text] [Related]  

  • 25. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business.
    Fernandes M; Miska D
    Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036
    [No Abstract]   [Full Text] [Related]  

  • 26. Global biotech expansion taking cues from Bayh-Dole.
    Howard K
    Nat Biotechnol; 2004 Jul; 22(7):919-20. PubMed ID: 15259190
    [No Abstract]   [Full Text] [Related]  

  • 27. The Bayh-Dole Act, a lion without claws.
    Feldman AM
    Clin Transl Sci; 2015 Feb; 8(1):3-4. PubMed ID: 25675969
    [No Abstract]   [Full Text] [Related]  

  • 28. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Funding and performance at the US Patent and Trademark Office.
    Hegde D
    Nat Biotechnol; 2012 Feb; 30(2):148-50. PubMed ID: 22318030
    [No Abstract]   [Full Text] [Related]  

  • 30. Federally funded stem cell research: a good deal for the taxpayer and consumer.
    Resnikoff DA
    Loyola Consum Law Rev; 2001; 14(1):36-56. PubMed ID: 15977330
    [No Abstract]   [Full Text] [Related]  

  • 31. License with care.
    Nat Med; 2013 Nov; 19(11):1351. PubMed ID: 24202370
    [No Abstract]   [Full Text] [Related]  

  • 32. Biobusiness on campus: commercialization of university-developed biomedical technologies.
    Dueker KS
    Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
    [No Abstract]   [Full Text] [Related]  

  • 33. Keeper of the stem cells.
    Lemonick MD
    Time; 2001 Aug; 158(8):57. PubMed ID: 11534482
    [No Abstract]   [Full Text] [Related]  

  • 34. Undermining TRIPS: protectionism at its worst.
    Lancet; 2007 Jan; 369(9555):2. PubMed ID: 17208619
    [No Abstract]   [Full Text] [Related]  

  • 35. The Bayh-Dole Act: a model for promoting research translation?
    Loewenberg S
    Mol Oncol; 2009 Apr; 3(2):91-3. PubMed ID: 19383372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the stimulus working for you?
    Freeman R; Block F; Greenberg D; Levi M; Segal AM; Crow M; Teitelbaum MS
    Nature; 2009 Oct; 461(7266):876-8. PubMed ID: 19829353
    [No Abstract]   [Full Text] [Related]  

  • 37. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferring innovation.
    Kesan JP
    Fordham Law Rev; 2009 Apr; 77(5):2169-223. PubMed ID: 19431909
    [No Abstract]   [Full Text] [Related]  

  • 39. Preserving our intellectual capital: the Canadian Institutes of Health Research funding crisis.
    Phillipson EA
    CMAJ; 2003 Sep; 169(6):568-9. PubMed ID: 12975224
    [No Abstract]   [Full Text] [Related]  

  • 40. Capitalizing on commercialization: should congress revisit the Bayh-Dole Act?
    Bruckbauer S
    J Natl Cancer Inst; 2003 Oct; 95(19):1429-31. PubMed ID: 14519745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.